GSK PLC SP. ADR/2 NEW Net Asset Quality Index
GSK PLC SP. ADR/2 NEW net asset quality index. GSK PLC SP. ADR/2 NEW (GS70) has a Net Asset Quality Index of 27.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €61.74 Billion minus total liabilities of €44.56 Billion yields net assets of €17.18 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of GSK PLC SP. ADR/2 NEW for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of GSK PLC SP. ADR/2 NEW (2021–2025)
Net asset quality index of GSK PLC SP. ADR/2 NEW from 2021 to 2025. This chart shows how GSK PLC SP. ADR/2 NEW's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 27.8%, representing net assets of €17.18 Billion against total assets of €61.74 Billion EUR. Check GSK PLC SP. ADR/2 NEW tangible equity quality to evaluate the tangible quality of the company's equity base.
GSK PLC SP. ADR/2 NEW Net Asset Quality Index by Year (2021–2025)
GSK PLC SP. ADR/2 NEW net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see GS70 market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 26.1% | €15.96 Billion | €61.12 Billion | €45.16 Billion | ▲ +4.1 pp |
| 2024 | 22.0% | €13.09 Billion | €59.46 Billion | €46.38 Billion | ▲ +0.3 pp |
| 2023 | 21.7% | €12.79 Billion | €59.01 Billion | €46.21 Billion | ▲ +4.9 pp |
| 2022 | 16.8% | €10.10 Billion | €60.15 Billion | €50.05 Billion | ▼ -10.2 pp |
| 2021 | 27.0% | €21.34 Billion | €79.10 Billion | €57.76 Billion | — |